UY39506A - Composiciones de fagos para pseudomonas que comprenden sistemas crispr-cas y métodos de uso de estas - Google Patents
Composiciones de fagos para pseudomonas que comprenden sistemas crispr-cas y métodos de uso de estasInfo
- Publication number
- UY39506A UY39506A UY0001039506A UY39506A UY39506A UY 39506 A UY39506 A UY 39506A UY 0001039506 A UY0001039506 A UY 0001039506A UY 39506 A UY39506 A UY 39506A UY 39506 A UY39506 A UY 39506A
- Authority
- UY
- Uruguay
- Prior art keywords
- crispr
- methods
- pseudomonas
- phages
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/40—Viruses, e.g. bacteriophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10041—Use of virus, viral particle or viral elements as a vector
- C12N2795/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063110288P | 2020-11-05 | 2020-11-05 | |
| US202163184728P | 2021-05-05 | 2021-05-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY39506A true UY39506A (es) | 2022-05-31 |
Family
ID=81458404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001039506A UY39506A (es) | 2020-11-05 | 2021-11-05 | Composiciones de fagos para pseudomonas que comprenden sistemas crispr-cas y métodos de uso de estas |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240011041A1 (enExample) |
| EP (1) | EP4240165A4 (enExample) |
| JP (1) | JP2023548581A (enExample) |
| AU (1) | AU2021373795A1 (enExample) |
| CA (1) | CA3197191A1 (enExample) |
| TW (1) | TW202233832A (enExample) |
| UY (1) | UY39506A (enExample) |
| WO (1) | WO2022098916A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115960895B (zh) * | 2022-08-09 | 2026-04-10 | 中国科学院微生物研究所 | 一种偶联的crispr和毒素-抗毒素元件及其在消杀耐药细菌中的应用 |
| EP4712993A2 (en) * | 2023-05-17 | 2026-03-25 | The Regents of the University of California | Phage therapy for alcohol-associated hepatitis |
| WO2025076308A1 (en) * | 2023-10-06 | 2025-04-10 | University Of Florida Research Foundation, Incorporated | Compositions and methods for analyzing the effect of microbiota on host protein conformation and treating neurodegenerative diseases |
| CN117959655B (zh) * | 2024-01-31 | 2026-06-23 | 四川大学 | 一种假单胞菌还原剂及其在钒还原中的应用和方法 |
| WO2025206239A1 (ja) * | 2024-03-28 | 2025-10-02 | 国立感染症研究所長が代表する日本国 | 組換えファージ及び遺伝子のスクリーニング方法 |
| WO2026150377A1 (en) | 2025-01-13 | 2026-07-16 | Locus Biosciences, Inc. | Bacteriophage compositions and uses for treatment of escherichia coli (e. coli) colonization |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107208070B (zh) * | 2014-11-26 | 2021-09-07 | 技术创新动力基金（以色列）有限合伙公司 | 细菌基因的靶向消除 |
| AU2016280002B2 (en) * | 2015-06-15 | 2022-04-14 | North Carolina State University | Methods and compositions for efficient delivery of nucleic acids and RNA-based antimicrobials |
| US9896696B2 (en) * | 2016-02-15 | 2018-02-20 | Benson Hill Biosystems, Inc. | Compositions and methods for modifying genomes |
| GB201710126D0 (en) * | 2017-06-25 | 2017-08-09 | Snipr Tech Ltd | Vectors & Methods |
| US20230193241A1 (en) * | 2017-06-25 | 2023-06-22 | Snipr Technologies Limited | Altering microbial populations & modifying microbiota |
| US20190160120A1 (en) * | 2017-11-29 | 2019-05-30 | Snipr Biome Aps | Dna, methods etc |
| KR20210018273A (ko) * | 2018-05-04 | 2021-02-17 | 로커스 바이오사이언스, 인크. | 표적 박테리아를 사멸시키기 위한 방법 및 조성물 |
| WO2019227080A1 (en) * | 2018-05-25 | 2019-11-28 | Locus Biosciences, Inc. | Methods and compositions for killing a target bacterium |
| US20220370526A1 (en) * | 2019-11-06 | 2022-11-24 | Locus Biosciences, Inc. | Phage compositions comprising crispr-cas systems and methods of use thereof |
-
2021
- 2021-11-04 US US18/035,227 patent/US20240011041A1/en active Pending
- 2021-11-04 TW TW110141211A patent/TW202233832A/zh unknown
- 2021-11-04 EP EP21890094.2A patent/EP4240165A4/en active Pending
- 2021-11-04 WO PCT/US2021/058123 patent/WO2022098916A1/en not_active Ceased
- 2021-11-04 CA CA3197191A patent/CA3197191A1/en active Pending
- 2021-11-04 JP JP2023527227A patent/JP2023548581A/ja active Pending
- 2021-11-04 AU AU2021373795A patent/AU2021373795A1/en not_active Abandoned
- 2021-11-05 UY UY0001039506A patent/UY39506A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA3197191A1 (en) | 2022-05-12 |
| US20240011041A1 (en) | 2024-01-11 |
| JP2023548581A (ja) | 2023-11-17 |
| EP4240165A1 (en) | 2023-09-13 |
| TW202233832A (zh) | 2022-09-01 |
| AU2021373795A1 (en) | 2023-06-22 |
| EP4240165A4 (en) | 2025-04-02 |
| WO2022098916A1 (en) | 2022-05-12 |
| AU2021373795A9 (en) | 2024-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2021003373A1 (es) | Nuevos inhibidores de egfr | |
| BR112021024224A2 (pt) | Inibidores de tead e usos dos mesmos | |
| MX2021014443A (es) | Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos. | |
| UY39135A (es) | ANTICUERPOS MONOCLONALES HUMANOS DIRIGIDOS CONTRAEL CORONAVIRUS 2 DEL SÍNDROME RESPIRATORIO AGUDO GRAVE (SARS-CoV-2) | |
| MX2022007576A (es) | Degradadores de cinasas asociadas al receptor de interleucina-1 (irak) y usos de los mismos. | |
| MX2022007527A (es) | Inhibidores de proteinas kras mutantes. | |
| CL2021001690S1 (es) | Estuche para audífonos. | |
| CO2022008662A2 (es) | Degradadores de smarca y usos de los mismos | |
| CO2018013557A2 (es) | Composiciones que comprenden cepas bacterianas | |
| CL2020000075A1 (es) | Carboxamidas como moduladores de los canales de sodio. | |
| MX2021013225A (es) | Composiciones y metodos para el tratamiento del cancer utilizando una terapia de celulas t modificadas de cd8. | |
| BR112018070133A2 (pt) | dispersão, uso desta e método para a inativação fotodinâmica de micro-organismos | |
| CL2021001175S1 (es) | Estuche para audífonos. | |
| CU20190092A7 (es) | Antimitoscinas: inhibidores específicos de la biogénesis mitocondrial para erradicar células madre cancerosas | |
| CL2020002052A1 (es) | Composiciones de edb que se dirigen a il-12. | |
| CL2023002198A1 (es) | Compuestos antiparasitarios. | |
| CL2021001461A1 (es) | Moduladores de trex1 | |
| CL2023003694A1 (es) | Anticuerpos anti-pcrv que se unen a pcrv, composiciones que comprenden anticuerpos anti-pcrv, métodos de uso | |
| AR114780A1 (es) | Formulaciones estables de inmunoconjugado anti-cd79b | |
| MX2020004179A (es) | Combinacion que comprende al menos un modulador de espliceosomas y al menos un inhibidor elegido de inhibidores de bcl2, bcl2/bclxl y bclxl, y metodos de uso. | |
| CO2019002751A2 (es) | Composiciones marcadoras, y metodos para fabricar y usar las mismas | |
| CL2022000807A1 (es) | Compuesto bicíclico y uso del mismo | |
| MX2022003001A (es) | Metodos para tratar el cancer mediante el uso de inhibidores del eje de pd-1 y anticuerpos anti-periostina. | |
| CO2025016192A2 (es) | Moléculas y métodos de uso de estas | |
| CL2021002501A1 (es) | Compuestos novedosos y métodos de uso de los mismos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20260415 |